↓ Skip to main content

Intravenous secretin for autism spectrum disorders (ASD)

Overview of attention for article published in Cochrane database of systematic reviews, April 2012
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news
1 news outlet
blogs
5 blogs
twitter
6 tweeters
patent
30 patents
facebook
1 Facebook page

Citations

dimensions_citation
39 Dimensions

Readers on

mendeley
143 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Intravenous secretin for autism spectrum disorders (ASD)
Published in
Cochrane database of systematic reviews, April 2012
DOI 10.1002/14651858.cd003495.pub3
Pubmed ID
Authors

Katrina Williams, John A Wray, Danielle M Wheeler

Abstract

In 1998 secretin, a gastrointestinal hormone, was suggested as an effective treatment for autism spectrum disorders (ASD) based on anecdotal evidence.

Twitter Demographics

The data shown below were collected from the profiles of 6 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 143 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Mexico 1 <1%
United States 1 <1%
Unknown 141 99%

Demographic breakdown

Readers by professional status Count As %
Researcher 25 17%
Student > Master 20 14%
Student > Bachelor 19 13%
Student > Ph. D. Student 17 12%
Student > Postgraduate 9 6%
Other 41 29%
Unknown 12 8%
Readers by discipline Count As %
Medicine and Dentistry 39 27%
Psychology 27 19%
Nursing and Health Professions 16 11%
Unspecified 7 5%
Social Sciences 7 5%
Other 28 20%
Unknown 19 13%

Attention Score in Context

This research output has an Altmetric Attention Score of 51. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 January 2020.
All research outputs
#402,529
of 14,800,128 outputs
Outputs from Cochrane database of systematic reviews
#1,047
of 11,056 outputs
Outputs of similar age
#2,425
of 123,719 outputs
Outputs of similar age from Cochrane database of systematic reviews
#3
of 99 outputs
Altmetric has tracked 14,800,128 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,056 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 22.6. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 123,719 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 99 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.